XML 36 R115.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Quarterly Data (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Quarterly Financial Data [Abstract]                      
Total revenue $ 605,446 $ 605,303 $ 620,103 $ 576,056 $ 549,386 $ 545,448 $ 580,752 $ 537,656 $ 2,406,908 $ 2,213,242 $ 1,969,058
Gross profit 331,149 344,950 357,853 331,597 300,361 305,643 332,439 303,099 1,365,549 1,241,542 1,097,382
Operating income 115,631 139,802 164,275 133,138 115,347 117,350 145,594 113,044 552,846 491,335 413,028
Net income attributable to IDEXX Laboratories, Inc. stockholders $ 90,496 $ 108,837 $ 125,706 $ 102,681 $ 85,638 $ 93,251 $ 108,691 $ 89,451 $ 427,720 $ 377,031 $ 263,144
Earnings per Share:                      
Basic (in USD per share) $ 1.05 $ 1.26 $ 1.46 $ 1.19 $ 0.99 $ 1.07 $ 1.25 $ 1.02 $ 4.97 $ 4.34 $ 3.00
Diluted (in USD per share) $ 1.04 $ 1.24 $ 1.43 $ 1.17 $ 0.98 $ 1.05 $ 1.23 $ 1.01 $ 4.89 $ 4.26 $ 2.94